Maxigen Biotech Inc. (TPE:1783)
Taiwan
· Delayed Price · Currency is TWD 39.40
+1.30 (3.41%)
Apr 29, 2026, 1:30 PM CST
Maxigen Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 3,417 | 3,838 | 4,365 | 4,304 | 4,036 | 3,996 | Upgrade
|
| Market Cap Growth | -10.88% | -12.06% | 1.40% | 6.65% | 0.99% | 151.22% | Upgrade
|
| Enterprise Value | 2,641 | 3,107 | 3,821 | 3,884 | 3,324 | 3,534 | Upgrade
|
| Last Close Price | 38.10 | 42.80 | 48.03 | 46.47 | 43.20 | 42.77 | Upgrade
|
| PE Ratio | 12.96 | 14.47 | 22.95 | 25.96 | 28.95 | 45.59 | Upgrade
|
| Forward PE | - | 10.53 | 10.53 | 10.53 | 10.53 | 10.53 | Upgrade
|
| PS Ratio | 4.21 | 4.73 | 6.41 | 6.92 | 6.68 | 7.81 | Upgrade
|
| PB Ratio | 2.22 | 2.50 | 3.17 | 3.16 | 3.12 | 3.50 | Upgrade
|
| P/TBV Ratio | 2.22 | 2.50 | 3.17 | 3.16 | 3.12 | 3.51 | Upgrade
|
| P/FCF Ratio | 16.40 | 18.42 | 16.38 | 28.94 | 15.89 | 38.67 | Upgrade
|
| P/OCF Ratio | 11.77 | 13.23 | 14.64 | 25.14 | 15.04 | 33.98 | Upgrade
|
| EV/Sales Ratio | 3.25 | 3.83 | 5.61 | 6.24 | 5.50 | 6.90 | Upgrade
|
| EV/EBITDA Ratio | 9.01 | 10.60 | 18.48 | 21.94 | 21.21 | 29.51 | Upgrade
|
| EV/EBIT Ratio | 10.12 | 11.90 | 21.24 | 25.92 | 25.84 | 39.28 | Upgrade
|
| EV/FCF Ratio | 12.67 | 14.91 | 14.34 | 26.11 | 13.08 | 34.20 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.07 | - | - | - | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.34 | 0.34 | - | - | - | 0.08 | Upgrade
|
| Debt / FCF Ratio | 0.48 | 0.48 | - | - | - | 0.09 | Upgrade
|
| Net Debt / Equity Ratio | -0.50 | -0.50 | -0.46 | -0.32 | -0.62 | -0.45 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.65 | -2.65 | -3.09 | -2.43 | -5.10 | -4.32 | Upgrade
|
| Net Debt / FCF Ratio | -3.72 | -3.72 | -2.40 | -2.90 | -3.15 | -5.01 | Upgrade
|
| Asset Turnover | 0.47 | 0.47 | 0.44 | 0.42 | 0.45 | 0.46 | Upgrade
|
| Inventory Turnover | 2.83 | 2.83 | 2.45 | 2.46 | 2.95 | 2.98 | Upgrade
|
| Quick Ratio | 2.89 | 2.89 | 3.61 | 4.02 | 5.94 | 5.53 | Upgrade
|
| Current Ratio | 3.21 | 3.21 | 4.03 | 4.72 | 6.56 | 6.75 | Upgrade
|
| Return on Equity (ROE) | 18.22% | 18.22% | 13.90% | 12.48% | 11.44% | 8.76% | Upgrade
|
| Return on Assets (ROA) | 9.39% | 9.39% | 7.31% | 6.37% | 5.93% | 5.06% | Upgrade
|
| Return on Invested Capital (ROIC) | 28.33% | 28.44% | 18.21% | 18.05% | 19.31% | 12.57% | Upgrade
|
| Return on Capital Employed (ROCE) | 16.90% | 16.90% | 13.10% | 11.00% | 9.90% | 7.80% | Upgrade
|
| Earnings Yield | 7.76% | 6.91% | 4.36% | 3.85% | 3.45% | 2.19% | Upgrade
|
| FCF Yield | 6.10% | 5.43% | 6.11% | 3.46% | 6.30% | 2.59% | Upgrade
|
| Dividend Yield | 2.18% | - | 1.73% | 2.15% | 1.10% | - | Upgrade
|
| Payout Ratio | 28.05% | 28.05% | 46.78% | 25.54% | - | 64.18% | Upgrade
|
| Buyback Yield / Dilution | -0.77% | -0.77% | -0.27% | -0.07% | -5.78% | -4.81% | Upgrade
|
| Total Shareholder Return | 1.40% | -0.77% | 1.46% | 2.08% | -4.68% | -4.81% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.